GlassScriptPhysician profile
Benjamin C Campbell
NPI 1609240613
$788.91
in general payments reported to CMS, 2019-2025
9 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2021: $24.24 · 2022: $81.58 · 2023: $72.12 · 2024: $62.73 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $165.63 | 2019 | |
| Horizon Therapeutics Plc | $142.05 | 2021-2023 | Tepezza |
| Alcon Vision LLC | $139.72 | 2019 | |
| Dompe US, INC. | $95.30 | 2025 | Oxervate |
| Boston Scientific Corporation | $88.08 | 2023-2025 | Lithovue, Accolade Sr |
| Amgen INC. | $84.75 | 2024-2025 | Tepezza |
| Leo Pharma INC. | $46.97 | 2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $15.82 | 2022 | |
| Biowound Solutions, INC. | $10.59 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.